Decreased accumulation of isopropyl-lodoamphetamine (I-123) in brain tumors.
Norman LaFrance, H.N. Wagner, Peter J. Whitehouse, E. Corley, Timothy Duelfer
Abstract
Norman LaFrance, H.N. Wagner, Peter J. Whitehouse, E. Corley, Timothy Duelfer
Abstract
Four out of four patients with brain tumors were observed to have impaired N-isopropyl-p-(/sup 123/I)iodoamphetamine (IAMPH) accumulation by the lesions even though brain scans with technetium-99m diethylenetriamine pentaccetic acid were normal in two. IAMPH may be a more sensitive means of detecting regional cerebral disease than tracers primarily sensitive to blood-flow abnormalities or impairment of the blood-brain barrier.
OpenAlex reports 53 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Four out of four patients with brain tumors were observed to have impaired N-isopropyl-p-(/sup 123/I)iodoamphetamine (IAMPH) accumulation by the lesions even though brain scans with technetium-99m diethylenetriamine pentaccetic acid were normal in two. IAMPH may be a more sensitive means of detecting regional cerebral disease than tracers primarily sensitive to blood-flow abnormalities or impairment of the blood-brain barrier.
Key concepts: Isopropyl, Cerebral blood flow, Medicine, Technetium, Blood–brain barrier, Iodine-123, Pathology, Blood flow